Kelly Godby
Interim Director, Hematology and Oncology · University of Alabama Hospital
Credentials: · · · ·
History
- 2008–2011
Hematology and Medical Oncology
- 2005–2008
Internal Medicine
2001–2005
Research
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy
Leukemia · 2019 · 559 citations
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
New England Journal of Medicine · 2022 · 422 citations
Blood Advances · 2017 · 261 citations
38 papers
- SB
29 papers
26 papers
26 papers · 1 as a fellow
18 papers
17 papers
16 papers
13 papers
Clinical trials
- 2019–2029
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
- 2026–2041
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
Sub-investigator · Recruiting · Phase 1
Susan Bal
- 2021–2028
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Sub-investigator · Recruiting · Phase 2
University of Alabama at Birmingham